- Vitamin D as a potential preventive agent for young women's breast cancer
- Conclusion
- Activating the Vitamin D Receptor increases Vitamin D
- CYP27B1 increases Vitamin D
- CYP24A1 decreases Vitamin D
- Overview Breast Cancer and Vitamin D contains:
- Getting Vitamin D into your body contains:
- CYP27B1 category listing contains:
- Cancers might alter CYP24A1 gene
- The risk of 44 diseases at least double with poor Vitamin D Receptor as of Oct 2019
- VitaminDWiki - Vitamin D Receptor activation can be increased in many ways
- Items in both categories Vitamin D Receptor and Cancer - Breast:
- Thus, the breasts try to increase receptor activation and Cancer cells try to decrease activation
Vitamin D as a potential preventive agent for young women's breast cancer
Cancer Prevention Research, DOI: 10.1158/1940-6207.CAPR-21-0114
Sarah M Bernhardt, Virgina F Borges and Pepper Schedin schedin at ohsu.edu
Clinical studies backed by research in animal models suggest that vitamin D may protect against the development of breast cancer, implicating vitamin D as a promising candidate for breast cancer prevention.
However, despite clear pre-clinical evidence showing protective roles for vitamin D, broadly targeted clinical trials of vitamin D supplementation have yielded conflicting findings, highlighting the complexity of translating pre-clinical data to efficacy in humans.
While vitamin D supplementation targeted to high-risk populations is a strategy anticipated to increase prevention efficacy, a complimentary approach is to target transient, developmental windows of elevated breast cancer risk. Postpartum mammary gland involution represents a developmental window of increased breast cancer promotion that may be poised for vitamin D supplementation.
Targeting the window of involution with short-term vitamin D intervention may offer a simple, cost-effective approach for the prevention of breast cancers that develop postpartum. In this review, we highlight epidemiologic and preclinical studies linking vitamin D deficiency with breast cancer development.
We discuss the underlying mechanisms through which vitamin D deficiency contributes to cancer development, with an emphasis on the anti-inflammatory activity of vitamin D. We also discuss current evidence for vitamin D as an immunotherapeutic agent and the potential for vitamin D as a preventative strategy for young woman's breast cancer
Section Titles
Overview of Vitamin D
Vitamin D signaling in breast cancer
Vitamin D in breast cancer progression and metastasis
Anti-inflammatory actions of vitamin D within the tumor microenvironment
Vitamin D as a therapeutic for the prevention of breast cancer
Targeting vitamin D to high-risk populations
Future research directions
Conclusion
There is strong evidence that downregulation of vitamin D signaling contributes to the development and progression of breast cancer. Epidemiological studies have linked vitamin D deficiency with an increased risk of breast cancer development; observations that are well-supported by research in animal models. However, while the potential for vitamin D as a breast cancer preventative agent is well-backed by pre-clinical data, clinical trials of vitamin D supplementation have produced modest and/or conflicting results. Vitamin D supplementation during transient, developmental windows of elevated risk may instead offer a more effective approach for the prevention of breast cancer. Post- lactational involution represents a key developmental window that may be poised for vitamin D supplementation. The unique demands for vitamin D during pregnancy and lactation emphasize vitamin D deficiency during the postpartum period, which in the background of the pro-inflammatory microenvironment of the involuting gland may enhance the tumor promotional attributes of involution. Attenuation of the inflammatory microenvironment of the vitamin D-deficient involuting breast with short-term vitamin D supplementation may offer protection against the development of postpartum breast cancer. Further research into the protective role of vitamin D against postpartum breast cancer development and progression is warranted.
 Download the PDF from VitaminDWiki
Note: This study indicates that Breast gets semiactivated Vitamin D p from the liver. Other studies indicate that the liver is not needed
Activating the Vitamin D Receptor increases Vitamin D
CYP27B1 increases Vitamin D
CYP24A1 decreases Vitamin D
Overview Breast Cancer and Vitamin D contains:
-
25 Meta-analyses of Vitamin D and Breast Cancer
example: 2X reduction of deaths from Breast Cancer if have enough Vitamin D.- Appears that having lots of Vitamin D will reduce by 3 X the chance of Breast Cancer
wonder just how much more proof is needed- Breast Cancer 4X more likely if have poor genes
- Cancer - Breast category listing has
259 items along with related searches - Breast Cancer treatment – Vitamin D was the most-popular supplement – Jan 2023
- Breast Cancer again associated with low vitamin D – 15th meta-analysis Sept 2020
- Vitamin D reduced Breast Cancer mortality in 9 out of 9 studies, yet still no consensus – April 2019
- Vitamin D both prevents and treats Breast Cancer – 2019
Getting Vitamin D into your body contains:
CYP27B1 category listing contains:
The CYP27B1 gene activates Vitamin D in the Kidney, Skin, Lungs, Brain, Eyes Breasts etc.
Poor CYP27B1 is assocated with COVID, Miscarriage, Lupus, Alz, Parkinson, MSA, RicketsCYtochrome P450 family 27 subfamily B member 1 = 25-Hydroxyvitamin D3 1-alpha-hydroxylase
63 items in CYP27B1 category 343 articles in the Genetics 530 articles in Vitamin D Receptor 177 articles in Vitamin D Binding Protein - CYP27B1 and other genes are less activated in seniors
- CYP27B causes many health problems – March 2020
- Every Parkinson’s brain had a poor CYP27B1 gene
What can be done if have a poor CYP27B1
- Larger doses of Vitamin D
- More Bio-available: Gut-friendly form, Topical form, taken with fatty meal, taken with evening meal
- Additional sources: UV
- Increase Vitamin D metabolism: additional Magnesium, Omega-3
- All cytochrome P450 enzymes require Mg++ as a cofactor
- Increase the amount of Vitamin D in the blood that gets to cells: increase activation of VDR
Vitamin D blood test misses CYP27B1 and other genes
Cancers might alter CYP24A1 gene
The risk of 44 diseases at least double with poor Vitamin D Receptor as of Oct 2019
VitaminDWiki - Vitamin D Receptor activation can be increased in many ways
Resveratrol, Omega-3, Magnesium, Zinc, Quercetin, non-daily Vit D, Curcumin, Berberine, intense exercise, Butyrate Sulforaphane Ginger, Essential oils, etc Note: The founder of VitaminDWiki uses 10 of the 16 known VDR activators
Items in both categories Vitamin D Receptor and Cancer - Breast:
- Breast Cancer prevented in 5 ways via the Vitamin D Receptor – Oct 2024
- Poor Vitamin D Receptor does not increase the risk of Breast Cancer (but the opposite is true) – umbrella meta-analysis Sept 2024
- An activated Vitamin D Receptor fights Autoimmune Diseases, Infections, Cancers, etc. – Dec 2023
- Breast Cancer risk reduced if consume butyrate - Dec 2023
- Breast cancer spreads to bone if poor vitamin D Receptor (no surprise) – Oct 2022
- Some breast cancers may be treated RNA changes caused by Vitamin D – March 2022
- Breast Cancer, Vitamin D, and genes – Welsh Nov 2021
- After lactation Vitamin D levels are low, increased risk of Breast Cancer, vitamin D should decrease risk – Aug 2021
- Breasts process Vitamin D and change gene activation, might prevent breast cancer if given more Vit. D – July 2021
- Breast cancer associated with Vitamin D Receptor (14th study) – Oct 2019
- After breast cancer treatment 4,000 IU of Vitamin D was not enough to help if have poor Vitamin D receptor – June 2019
- Breast Cancer death 1.8 X more likely if poor Vitamin D Receptor – April 2019
- Breast Cancer and Vitamin D review – March 2018
- Women with Breast Cancer were 16.9 times more likely to have a poor Vitamin D Receptor – Jan 2019
- Cancer treatment by Vitamin D sometimes is restricted by genes – Oct 2018
- Two chemicals increase the Vitamin D receptor and decrease the growth of breast cancer cells in the lab - March 2018
- Breast Cancer reduces receptor and thus blocks Vitamin D to the cells – several studies
- Vitamin D receptor as a target for breast cancer therapy (abstract only) – Feb 2017
- Breast Cancer was 4.6 times more likely if have a poor Vitamin D Receptor – Dec 2016
- Increased Breast Cancer metastasis if low vitamin D or poor VDR – Feb 2016
- Increased risk of some female cancers if low vitamin D (due to genes) – meta-analysis June 2015
- Vitamin D receptor in breasts and breast cancer vary with race – March 2013
- Breast Cancer incidence change by 40 percent with vitamin D receptor genes – Oct 2012
- Genes breast cancer and vitamin D receptor - Sept 2010
Thus, the breasts try to increase receptor activation and Cancer cells try to decrease activation
- Breast cancer and Vitamin D receptors, CP27B1, and CYP24A1 – Sept 2010 chart shows gene changes with breast Cancer
Breasts process Vitamin D and change gene activation, might prevent breast cancer if given more Vit. D – July 20214848 visitors, last modified 05 Jan, 2024, This page is in the following categories (# of items in each category)Attached files
ID Name Uploaded Size Downloads 15894 Prevent CYP24A1.jpg admin 10 Jul, 2021 58.38 Kb 436 15893 Prevent CYP27B1.jpg admin 10 Jul, 2021 57.94 Kb 425 15892 Prevent VDR.jpg admin 10 Jul, 2021 58.58 Kb 426 15891 Prevent1.jpg admin 10 Jul, 2021 141.11 Kb 492 15890 prevent young women's breast cancer_compressed.pdf admin 10 Jul, 2021 329.53 Kb 325
- Appears that having lots of Vitamin D will reduce by 3 X the chance of Breast Cancer